Arun J. Sanyal, Thomas D. Boyer, Norah A. Terrault. (2018). Neurological Consequences of Liver Disease. In Zakim and Boyer’s Hepatology A Textbook of Liver Disease (7th ed., pp. 203-219).
Butterworth, R. F., & Gruengreiff, K. (2018). L-ornithine L-aspartate for the treatment of hepatic encephalopathy in cirrhosis: Evidence for novel hepatoprotective mechanisms. Scimed Central. Retrieved from https://www.jscimedcentral.com/Liver/liver-5-1044.pdf
Hepatex- P (L Ornithine L Aspartate + Pancreatin). Texas Pharmaceuticals Pvt Ltd. Retrieved from https://www.texasusa.in/product/hepatex-p/
Hepalair Tablet (L Ornithine L Aspartate + Pancreatin). Leeford Healthcare Ltd. Retrieved from https://www.leeford.in/product/699/hepalair-tablets
Ornipan (L Ornithine L Aspartate + Pancreatin). Moraceae Pharmaceuticals Pvt Ltd. Retrieved from https://moraceae.org/product/ornipan-tablet/
L Ornithine (L Aspartate + Pancreatin). Actiza Pharma. Retrieved from https://www.actizapharma.com/products/l-ornithine-l-aspartate-pancreatin-tablets/
Hepa-Merz granules. (2021). Retrieved from https://www.hepa-merz.com/
Hepagurd granules. (2021). Retrieved from https://www.beximcopharma.com/
Pancrease HL Capsules - Summary of Product Characteristics (SmPC). (2021). Retrieved from https://www.medicines.org.uk/emc/
Pancrease HL Capsules - Patient Information Leaflet (PIL). (2021). Retrieved from https://www.medicines.org.uk/emc/
L-ornithine L-aspartate for prevention and treatment of. (n.d.). Retrieved from https://pubmed.ncbi.nlm.nih.gov/29762873/
Pancrelipase: MedlinePlus Drug Information. (n.d.). Retrieved from https://medlineplus.gov/druginfo/meds/a604035.html
HIGHLIGHTS OF PRESCRIBING INFORMATION. (n.d.). https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020725s000lbl.pdf
CFR - Code of federal regulations title 21. (2023, June 7). https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=310.543